newsfilter
← Latest News
GlobeNewswire·

Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results

Topline data from two ongoing COVID-19 studies with KB109 expected in Q1 2021 KB295 study in patients with ulcerative colitis remains on track with topline data anticipated mid-year 2021 LEXINGTON,...